Evereden Intensive Eczema Balm 2 g/100g
Colloidal Oatmeal · OINTMENT · Eden Brands Inc.
Evereden Intensive Eczema Balm is a ointment containing colloidal oatmeal at 2 g/100g, taken topical. Manufactured by Eden Brands Inc..
Key Facts
- Brand Name
- Evereden Intensive Eczema Balm
- Generic Name
- Colloidal Oatmeal
- NDC Code (Product)
72113-109- Manufacturer
- Eden Brands Inc.
- Strength
- 2 g/100g
- Dosage Form
- OINTMENT
- Route
- TOPICAL
- Marketing Status
- Application #
- M016
- Drug Class
- Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]
- Marketing Start
- 11/18/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Evereden Intensive Eczema Balm used for?
Evereden Intensive Eczema Balm contains Colloidal Oatmeal. It is a ointment taken topical. Consult your doctor for specific uses.
Is Evereden Intensive Eczema Balm a controlled substance?
Evereden Intensive Eczema Balm is not classified as a controlled substance by the DEA.
What is the generic name for Evereden Intensive Eczema Balm?
The generic name for Evereden Intensive Eczema Balm is Colloidal Oatmeal. There are 12 other brand versions of Colloidal Oatmeal.
What is the NDC code for Evereden Intensive Eczema Balm 2 g/100g?
The NDC (National Drug Code) for Evereden Intensive Eczema Balm 2 g/100g is 72113-109, listed by Eden Brands Inc..
Other Colloidal Brands
See all →- Barrier Balm1 g/100g73088-305
- Skin Mercy Intense Recovery Cream1 g/100mL80921-001
- First Aid Beauty FAB Ultra Repair Skin Protectant Vanilla Latte.5 g/100g84126-047
- First Aid Beauty Dry Skin Rescue Kit84126-220
- Tagrid Eczema Cream Colloidal Oatmeal 1%1 g/100g85384-0024
- Eczema Itch Relief Wash and Shampo15 mg/mL10738-162
- Gold Bond Eczema Relief Medicated Skin Protectant Cream2 g/100g41167-0669
- Eczema Relief10 mg/11g55910-653
- Baby Eczema Therapy10.4 kg/g55910-803
- AL0043600 Alba Botanica VE Herbal Healing Body.4 g/100g61995-2436
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)